124 related articles for article (PubMed ID: 23377513)
1. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
Leyden JJ
J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
Leyden JJ
Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
Lim YH; Kim IH; Seo JJ
J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
Gans EH; Kligman AM
J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
6. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
Leyden J; Kaidbey K; Levy SF
Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253
[TBL] [Abstract][Full Text] [Related]
7. The development of antibiotic resistance in Propionibacterium acnes.
Leyden J; Levy S
Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M; Wasik B; Becker A; Höffler U
Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
[TBL] [Abstract][Full Text] [Related]
9. The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/ tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers.
Murray J; Potts A
J Drugs Dermatol; 2014 Jan; 13(1):16-22. PubMed ID: 24385115
[TBL] [Abstract][Full Text] [Related]
10. [Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].
Komagata Y; Komiyama K; Nomura S
Jpn J Antibiot; 1998 Feb; 51(2):130-6. PubMed ID: 9575439
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
13. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
Abeck D
MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
[No Abstract] [Full Text] [Related]
14. Antibacterial activity of retinaldehyde against Propionibacterium acnes.
Pechère M; Pechère JC; Siegenthaler G; Germanier L; Saurat JH
Dermatology; 1999; 199 Suppl 1():29-31. PubMed ID: 10473957
[TBL] [Abstract][Full Text] [Related]
15. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
16. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity and post-antibiotic effect of ozenoxacin against Propionibacterium acnes.
Kanayama S; Okamoto K; Ikeda F; Ishii R; Matsumoto T; Hayashi N; Gotoh N
J Infect Chemother; 2017 Jun; 23(6):374-380. PubMed ID: 28389164
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic sensitivity of comedonal Propionibacterium acnes.
Guin JD; Huber DS; Gielerak PL
Acta Derm Venereol; 1979; 59(6):552-54. PubMed ID: 94223
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of NB-003 against Propionibacterium acnes.
Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Ma L; Sutcliffe J; Baker JR
Antimicrob Agents Chemother; 2011 Sep; 55(9):4211-7. PubMed ID: 21746943
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
Puhvel SM
Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
